MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

A Pharmacodynamic Study of the P-glycoprotein Antagonist CBT-1 in Combination With Paclitaxel in Solid Tumors

Kelly RJ et al. – CBT–1 is able to inhibit Pgp–mediated efflux from PBMCs and normal liver to a degree observed with Pgp inhibitors studied in earlier clinical trials. Combined with its ease of administration and lack of toxicity, the data showing inhibition of normal tissue Pgp support further studies with CBT–1 to evaluate its ability to modulate drug uptake in tumor tissue. [more...]